A crystal form of an LPAR1 inhibitor, pharmaceutical compositions comprising the crystal form, and their uses.

TW202637149APending Publication Date: 2026-09-16WUHAN LL SCI & TECH DEV CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115102862
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2026-01-20
Filing Date
2026-01-23
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001077104_001
    Figure TWG2TA001077104_001
  • Figure TWG2TA001077104_002
    Figure TWG2TA001077104_002
  • Figure TWG2TA001077104_003
    Figure TWG2TA001077104_003
Patent Text Reader

Abstract

This invention discloses a crystal form of an LPAR1 inhibitor, a pharmaceutical composition comprising the crystal form, and their uses. The LPAR1 inhibitor is compound I or a stereoisomer thereof, and its crystal forms include crystal form A, crystal form B, crystal form C, crystal form D, crystal form E, or crystal form F. All crystal forms possess stable physical and chemical properties, good processability, and superior in vitro and in vivo biological performance, indicating broad application prospects.
Need to check novelty before this filing date? Find Prior Art